SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
Metastatic disease is the major reason for breast cancer-related deaths; therefore, a better understanding of this process and its players is needed. Here the authors report the role of SIRT7 in inhibiting SMAD4-mediated breast cancer metastasis providing a possible therapeutic avenue.
Main Authors: | Xiaolong Tang, Lei Shi, Ni Xie, Zuojun Liu, Minxian Qian, Fanbiao Meng, Qingyang Xu, Mingyan Zhou, Xinyue Cao, Wei-Guo Zhu, Baohua Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-00396-9 |
Similar Items
-
SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication
by: Teng Meng, et al.
Published: (2020-11-01) -
Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis
by: Xiaolong Tang, et al.
Published: (2021-08-01) -
Synergy between SIRT1 and SIRT6 helps recognize DNA breaks and potentiates the DNA damage response and repair in humans and mice
by: Fanbiao Meng, et al.
Published: (2020-06-01) -
Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria
by: Minxian Qian, et al.
Published: (2018-05-01) -
TGFβ-facilitated optic fissure fusion and the role of bone morphogenetic protein antagonism
by: Max D. Knickmeyer, et al.
Published: (2018-03-01)